NBIX - Neurocrine Biosciences Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - NBIX (914475)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
83 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2023-12-06
NBIXRoberts EiryChief Medical OfficerS - Sale+OE$120.03-8,39629,521-22%-$1,007,780
D
2023-12-06
NBIXLippoldt DarinGCS - Sale+OE$119.86-20,83035,882-37%-$2,496,648
D
2023-12-01
NBIXLyons Gary ADirS - Sale+OE$116.77-5,000203,697-2%-$583,837
2023-11-29
NBIXOnyia JudeChief Scientific OfficerS - Sale$113.57-2,33111,732-17%-$264,733
2023-11-27
NBIXLippoldt DarinGCS - Sale$112.27-10,91935,882-23%-$1,225,911
2023-10-02
NBIXBoyer David W.Chief Corp. Affairs OfficerS - Sale$112.68-1,4374,894-23%-$161,921
D
2023-09-12
NBIXLyons Gary ADirS - Sale+OE$115.02-5,000203,697-2%-$575,120
D
2023-09-01
NBIXLyons Gary ADirS - Sale+OE$110.06-5,000203,697-2%-$550,316
2023-09-01
NBIXCooke JulieCHROS - Sale$110.93-82417,263-5%-$91,406
2023-08-30
NBIXBoyer David W.Chief Corp. Affairs OfficerS - Sale$107.60-2,7333,460-44%-$294,058
2023-08-28
NBIXDelaet IngridChief Regulatory OfficerS - Sale$107.52-1,4315,931-19%-$153,861
2023-08-21
NBIXRoberts EiryChief Medical OfficerS - Sale$107.38-3,19829,521-10%-$343,388
2023-08-21
NBIXOnyia JudeChief Scientific OfficerS - Sale$107.37-3,1989,638-25%-$343,368
2023-08-21
NBIXLippoldt DarinGCS - Sale$107.39-2,13246,991-4%-$228,951
2023-08-21
NBIXGorman Kevin CharlesCEOS - Sale$107.40-9,328499,754-2%-$1,001,816
2023-08-21
NBIXGano KyleChief Business Development OffS - Sale$107.41-2,132130,250-2%-$228,993
2023-08-21
NBIXDelaet IngridChief Regulatory OfficerS - Sale$107.42-1,4044,645-23%-$150,820
2023-08-21
NBIXCooke JulieCHROS - Sale$107.41-2,13218,087-11%-$228,991
2023-08-21
NBIXBoyer David W.Chief Corp. Affairs OfficerS - Sale$107.41-1,6006,193-21%-$171,862
2023-08-21
NBIXBenevich EricChief Commercial OfficerS - Sale$107.40-1,60036,436-4%-$171,836
2023-08-21
NBIXAbernethy MattCFOS - Sale$107.39-2,13227,131-7%-$228,958
D
2023-05-01
NBIXRastetter William HDirS - Sale+OE$101.43-4,30042,785-9%-$436,135
2023-05-01
NBIXCooke JulieCHROS - Sale$103.89-11,39716,169-41%-$1,184,049
2023-04-25
NBIXCooke JulieCHROS - Sale$103.82-10027,5610%-$10,382
2023-04-24
NBIXRoberts EiryChief Medical OfficerS - Sale$103.48-14,40026,644-35%-$1,490,059
DM
2023-04-19
NBIXRastetter William HDirS - Sale+OE$105.03-6,93739,460-15%-$728,605
M
2023-02-06
NBIXCooke JulieCHROS - Sale$102.77-17,07927,424-38%-$1,755,121
M
2023-02-06
NBIXRoberts EiryChief Medical OfficerS - Sale$102.74-16,52541,015-29%-$1,697,707
2023-02-07
NBIXOnyia JudeChief Scientific OfficerS - Sale$102.30-4,5086,525-41%-$461,166
M
2023-02-06
NBIXLloyd-Smith MalcolmChief Integration OfficerS - Sale$102.64-15,31842,337-27%-$1,572,197
M
2023-02-06
NBIXLippoldt DarinGCS - Sale$102.71-16,27544,973-27%-$1,671,637
M
2023-02-06
NBIXGorman Kevin CharlesCEOS - Sale$102.90-29,044491,365-6%-$2,988,758
M
2023-02-06
NBIXGano KyleChief Business Development OffS - Sale$102.80-17,004128,096-12%-$1,747,920
M
2023-02-06
NBIXBoyer David W.Chief Corp. Affairs OfficerS - Sale$102.49-25,2384,755-84%-$2,586,741
M
2023-02-06
NBIXBenevich EricChief Commercial OfficerS - Sale$102.70-19,65034,381-36%-$2,018,105
M
2023-02-06
NBIXAbernethy MattCFOS - Sale$102.61-28,58825,213-53%-$2,933,470
2023-01-31
NBIXRoberts EiryChief Medical OfficerS - Sale$109.99-1,45726,171-5%-$160,254
2023-01-31
NBIXOnyia JudeChief Scientific OfficerS - Sale$108.48-1262,477-5%-$13,668
2023-01-31
NBIXLloyd-Smith MalcolmChief Integration OfficerS - Sale$110.02-1,66628,582-6%-$183,290
2023-01-31
NBIXLippoldt DarinGCS - Sale$109.97-1,25030,357-4%-$137,464
2023-01-31
NBIXGorman Kevin CharlesCEOS - Sale$110.08-2,707465,278-1%-$297,997
2023-01-31
NBIXGano KyleChief Business Development OffS - Sale$109.99-1,541112,820-1%-$169,486
2023-01-31
NBIXCooke JulieCHROS - Sale$108.48-91615,926-5%-$99,368
2023-01-31
NBIXBoyer David W.Chief Corp. Affairs OfficerS - Sale$109.92-1,1043,911-22%-$121,349
2023-01-31
NBIXBenevich EricChief Commercial OfficerS - Sale$109.95-1,20716,729-7%-$132,710
2023-01-31
NBIXAbernethy MattCFOS - Sale$109.98-1,28321,357-6%-$141,108
D
2023-01-06
NBIXBenevich EricChief Commercial OfficerS - Sale+OE$125.00-40015,643-2%-$50,000
D
2023-01-03
NBIXSherwin Stephen ADirS - Sale+OE$118.86-30,00025,055-54%-$3,565,728
D
2023-01-03
NBIXPops Richard FDirS - Sale+OE$119.20-15,00029,512-34%-$1,788,045
D
2022-11-30
NBIXBenevich EricChief Commercial OfficerS - Sale+OE$125.90-50,00015,643-76%-$6,295,085
2022-11-29
NBIXOnyia JudeChief Scientific OfficerS - Sale$121.91-2,3312,366-50%-$284,160
DM
2022-11-08
NBIXBenevich EricChief Commercial OfficerS - Sale+OE$125.33-24,69315,643-61%-$3,094,856
D
2022-11-08
NBIXLippoldt DarinGCS - Sale+OE$125.04-5,08229,234-15%-$635,442
D
2022-11-08
NBIXCooke JulieCHROS - Sale+OE$124.99-5,59215,102-27%-$698,949
D
2022-11-03
NBIXLippoldt DarinGCS - Sale+OE$125.02-4,51829,234-13%-$564,851
DM
2022-11-02
NBIXCooke JulieCHROS - Sale+OE$125.00-8,40815,102-36%-$1,050,997
DM
2022-11-02
NBIXBenevich EricChief Commercial OfficerS - Sale+OE$125.02-9,36815,643-37%-$1,171,183
D
2022-10-31
NBIXLyons Gary ADirS - Sale+OE$114.76-15,000203,697-7%-$1,721,403
DM
2022-11-01
NBIXLippoldt DarinGCS - Sale+OE$120.28-10,40029,234-26%-$1,250,899
2022-10-31
NBIXBoyer David W.Chief Corp. Affairs OfficerS - Sale$114.12-1,2952,919-31%-$147,785
DM
2022-10-26
NBIXLippoldt DarinGCS - Sale+OE$115.03-10,00029,234-25%-$1,150,297
2022-10-17
NBIXBenevich EricChief Commercial OfficerS - Sale$110.82-4,96015,643-24%-$549,682
2022-10-03
NBIXBoyer David W.Chief Corp. Affairs OfficerS - Sale$106.59-1,4374,214-25%-$153,170
2022-10-04
NBIXLyons Gary ADirS - Sale$110.54-5,000203,697-2%-$552,711
D
2022-10-04
NBIXLippoldt DarinGCS - Sale+OE$111.05-10,00029,234-25%-$1,110,446
D
2022-08-12
NBIXLloyd-Smith MalcolmChief Regulatory OfficerS - Sale+OE$105.95-21,53326,931-44%-$2,281,331
2022-06-27
NBIXCooke JulieCHROS - Sale$100.00-75416,918-4%-$75,400
D
2022-05-09
NBIXPops Richard FDirS - Sale+OE$76.30-15,00029,512-34%-$1,144,463
D
2022-04-25
NBIXLyons Gary ADirS - Sale+OE$92.76-15,000208,697-7%-$1,391,393
D
2022-04-01
NBIXRastetter William HDirS - Sale+OE$94.93-10,72834,022-24%-$1,018,366
M
2022-03-18
NBIXLippoldt DarinGCS - Sale$95.05-8,75529,396-23%-$832,156
M
2022-02-07
NBIXBoyer David W.Chief Corp. Affairs OfficerS - Sale$79.99-9402,919-24%-$75,193
M
2022-02-07
NBIXRoberts EiryChief Medical OfficerS - Sale$80.45-3,72424,625-13%-$299,590
M
2022-02-07
NBIXLloyd-Smith MalcolmChief Regulatory OfficerS - Sale$80.48-3,38218,731-15%-$272,168
M
2022-02-07
NBIXLippoldt DarinGCS - Sale$80.45-4,07938,112-10%-$328,160
M
2022-02-07
NBIXGorman Kevin CharlesCEOS - Sale$80.54-10,984462,844-2%-$884,674
M
2022-02-07
NBIXGano KyleChief Business Development OffS - Sale$80.61-6,880111,173-6%-$554,628
M
2022-02-07
NBIXCooke JulieCHROS - Sale$80.38-2,85817,411-14%-$229,727
M
2022-02-07
NBIXBenevich EricChief Commercial OfficerS - Sale$80.57-5,09920,338-20%-$410,821
M
2022-02-07
NBIXAbernethy MattCFOS - Sale$80.53-4,29020,204-18%-$345,486
D
2022-01-24
NBIXSherwin Stephen ADirS - Sale+OE$74.43-15,00025,055-37%-$1,116,378
2022-01-10
NBIXRoberts EiryChief Medical OfficerS - Sale$74.50-2,63221,279-11%-$196,088
D
2022-01-05
NBIXGano KyleChief Business Development OffS - Sale+OE$85.50-28,266104,984-21%-$2,416,751

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top